Discover the programme led by a distinguished faculty and register today. Special registration rates for trainees, residents and ILCA Members!
Renew your membership or become a new member today and enjoy exclusive educational and networking benefits throughout 2019.
Despite numerous large studies over the past decade for patients with unresectable hepatocellular carcinoma (HCC), a second-line standard of care remained largely elusive following standard [...]
Prof. Richard Finn on Finding a Biomarker for Patients with HCC − Biomarker selection for systemic treatments has become a challenge in this particular field, Prof. Finn says.
Renew your membership or become a new member today and enjoy exclusive educational and networking benefits throughout 2017.